Pharmacogenomic Dosing in Kidney Transplant Patients Converted from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®).

被引:0
|
作者
Belfield, K. D. [1 ]
Armstrong, K. J. [2 ]
Malhotra, D. [3 ]
Girone, G. F. [1 ]
机构
[1] Yale New Haven Med Ctr, Dept Pharm, New Haven, CT USA
[2] Hosp Cent Connecticut, Dept Pharm, New Britain, CT USA
[3] Yale Sch Med, Nephrol Sect, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B117
引用
收藏
页码:786 / 787
页数:2
相关论文
共 50 条
  • [1] EVALUATING THE CONVERSION OF PATIENTS TO EXTENDED-RELEASE TACROLIMUS (ENVARSUS XR®) FROM IMMEDIATE RELEASE (IR)-TACROLIMUS IN LIVER TRANSPLANT RECIPIENTS
    Choi, David
    Thaker, Sarang
    West-Thielke, Patricia
    Elmasri, Annesti
    Chan, Christine
    HEPATOLOGY, 2020, 72 : 804A - 804A
  • [2] Conversion from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®): A Real World Cohort Highlighting Dosing Variability among Patients.
    Belfield, K. D.
    Malhotra, D.
    Waleed, M.
    Cohen, E. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 687 - 687
  • [3] Pharmacokinetic Evaluation of a De Novo Envarsus XR® (tacrolimus Extended Release) Dosing Strategy in Kidney Transplant Recipients
    Schulte, J.
    Kane, C.
    Cunningham, K.
    D'Agostino, C.
    Kapugi, M.
    Novak, A.
    Shetty, A.
    Leventhal, J.
    Friedewald, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 920 - 921
  • [4] Efficacy of a De Novo Tacrolimus Extended Release (Envarsus XR®) Dosing Algorithm
    Belfield, K. D.
    Marvin, J. E.
    Girone, G. F.
    Do, V.
    Cohen, E. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S951 - S952
  • [5] Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS)
    Fleming, James N.
    Salas, Maria A. Posadas
    Taber, David J.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (03) : 415 - 420
  • [6] Cognitive Outcomes and Quality of Life in Stable Renal Transplant Patients Switched from Twice-Daily Immediate Release Tacrolimus to Once Daily Extended-Release Tacrolimus (Envarsus XR™)
    Langone, A.
    Paueksakon, B.
    Ervin, H.
    Clemens, J.
    Sika, M.
    Jackson, J. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S851 - S853
  • [7] Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients.
    Foster, E.
    Iaria, A.
    Negrelli, J.
    Fine, M.
    Yu, M.
    Liebo, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 843 - 843
  • [8] Comparison of Immediate-Release Tacrolimus to Envarsus XR on the Development of Donor Specific Antibodies in Kidney Transplant Recipients.
    Arora, R. A.
    Kane, C.
    Lang, K.
    Kapugi, M.
    D'Agostino, C.
    Cunningham, K.
    Park, S. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 401 - 401
  • [9] Impact of obesity on the conversion of immediate-release tacrolimus to extended-release tacrolimus in kidney transplant recipients
    Newman, Jessica
    Patel, Neha
    Patel, Shikha
    Sprague, Taylor
    Bartlett, Felicia
    Rao, Nikhil
    Andrade, Erika
    Rohan, Vinayak
    Dubay, Derek
    Casey, Michael J.
    Taber, David
    CLINICAL TRANSPLANTATION, 2023, 37 (12)
  • [10] MUSEKAL - ASSESSING TOLERABILITY AND EFFECTIVENESS OF EXTENDED-RELEASE TACROLIMUS (LCPT) IN KIDNEY TRANSPLANT PATIENTS CONVERTED FROM OTHER TACROLIMUS FORMULATIONS
    Saeemann, Marcus
    Schneeberger, Stefan
    Schmidt, Alice
    Rosenkranz, Alexander
    TRANSPLANT INTERNATIONAL, 2021, 34 : 26 - 26